Close
Nordic 9Nordic 9

Ridgeback Capital Management (investor - Private Equity)

United States ridgebackcap.com
See something wrong or missing? Let us know
Offices:New York

Ridgeback Capital is a private investment company that is focused on investing in life science companies. 

Average round investment:156M USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: United Kingdom Quell Therapeutics
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Ridgeback Capital Management

Name Criteria
Japan Nikon
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Monashee Investment Management
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Wellington Management
81%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Arab Emirates Chimera Investment
80%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Sweden AP3
80%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Cowen Healthcare Investments
80%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway Watrium
80%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom M&G Investments
79%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Switzerland Endeavour Vision
79%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Ireland KCK Group
78%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top